These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7958640)

  • 1. [Percutaneous administration of collagen (VasoSeal): an efficacious system of hemostasis after catheterization or interventional procedures using arterial approach].
    Sganzerla P; Fabbiocchi F; Montorsi P; Loaldi A; Passaretti B; Bartorelli AL
    G Ital Cardiol; 1994 Aug; 24(8):985-92. PubMed ID: 7958640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of a hemostatic device with percutaneous collagen application (VasoSeal) compared to a mechanical compression system (Compressar) after transfemoral catheterization of patients suffering from arterial occlusive disease].
    Neudecker A; Manke C; Lenhart M; Zorger N; Paetzel C; Feuerbach S; Link J
    Rofo; 2003 May; 175(5):676-81. PubMed ID: 12743862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures.
    Nader RG; Garcia JC; Drushal K; Pesek T
    J Invasive Cardiol; 2002 Jun; 14(6):305-7. PubMed ID: 12042620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoral haemostosis with Vasoseal ES: experience in 150 patients.
    Gazzera C; Doriguzzi Breatta A; Veltri A; Righi D; Barbero S; Balderi A; Petracchini M; Gandini G
    Radiol Med; 2005; 109(1-2):118-24. PubMed ID: 15729192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.
    Eggebrecht H; Haude M; Woertgen U; Schmermund A; von Birgelen C; Naber C; Baumgart D; Kaiser C; Oldenburg O; Bartel T; Kroeger K; Erbel R
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):486-95. PubMed ID: 12455083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving femoral artery hemostasis after cardiac catheterization: a comparison of methods.
    Schickel SI; Adkisson P; Miracle V; Cronin SN
    Am J Crit Care; 1999 Nov; 8(6):406-9. PubMed ID: 10553181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx.
    Scheinert D; Sievert H; Turco MA; Schmidt A; Hauptmann KE; Mueller R; Dadourian D; Krankenberg H; Grube E
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):627-33. PubMed ID: 17960627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization.
    Doyle BJ; Godfrey MJ; Lennon RJ; Ryan JL; Bresnahan JF; Rihal CS; Ting HH
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):203-8. PubMed ID: 17195965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device.
    Bavry AA; Raymond RE; Bhatt DL; Chambers CE; DeNardo AJ; Hermiller JB; Myers PR; Pitts DE; Scott JA; Savader SJ; Steinhubl S
    J Invasive Cardiol; 2008 Apr; 20(4):152-6. PubMed ID: 18398227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device.
    Eggebrecht H; von Birgelen C; Naber C; Kröger K; Schmermund A; Wieneke H; Bartel T; Wörtgen U; Baumgart D; Haude M; Erbel R
    J Invasive Cardiol; 2004 May; 16(5):247-50. PubMed ID: 15152129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Femoral Arterial Hemostasis using the Angio-Sealª System after Coronary and Vascular Percutaneous Angioplasty and Stenting.
    Cremonesi A; Castriota F; Tarantino F; Troiani E; Ricci E; El Jamal B ; Grattoni C; Noera G
    J Invasive Cardiol; 1998 Oct; 10(8):464-469. PubMed ID: 10762823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial puncture closure using a collagen plug, II. (VasoSeal).
    Cleveland G; Hill S; Williams S
    Tech Vasc Interv Radiol; 2003 Jun; 6(2):82-4. PubMed ID: 12903001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of hemostatic puncture closing device for hemostasis and early ambulation after coronary angiography and angioplasty: results of a multicenter trial].
    Magosaki N; Hosoda S; Kawagishi N; Yamaguchi T; Sakatani H; Haze K; Itagane H; Otsuka M; Nobuyoshi M; Yokoi H
    J Cardiol; 1999 Sep; 34(3):131-8. PubMed ID: 10500973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel femoral artery puncture closure device in patients undergoing interventional and diagnostic cardiac procedures.
    Mehta H; Fleisch M; Chatterjee T; Windecker S; Garachermani A; Eberli FR; Meier B
    J Invasive Cardiol; 2002 Jan; 14(1):9-12. PubMed ID: 11773688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience of StarClose vascular closure device in patients with first and recurrent femoral punctures.
    Tay EL; Co M; Tai BC; Lee YP; Low A; Lim YT; Tan HC; Lee CH
    J Interv Cardiol; 2008 Feb; 21(1):67-73. PubMed ID: 18254789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device.
    Eggebrecht H; Naber C; Woertgen U; Ringe S; Konorza TF; Schmermund A; von Birgelen C; Haude M; Kroeger K; Erbel R; Baumgart D
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):313-21. PubMed ID: 12594694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility study of NeoMend, a percutaneous arterial closure device that uses a nonthrombogenic bioadhesive.
    Funovics MA; Wolf F; Philipp MO; Kee S; Tichy B; Dirisamer A; Rand T; Lammer J
    AJR Am J Roentgenol; 2003 Feb; 180(2):533-8. PubMed ID: 12540467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immediate hemostasis of the femoral artery after heart catheterization: the present situation of closure systems].
    Lochow P; Silber S
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1753-8. PubMed ID: 15295687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First human experience of thermal arterial closure.
    Davidson LJ; Luna J; Virmani R; Asscher JA; Davidson CJ
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):30-6. PubMed ID: 23934606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.